Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Activation of the LIMK/Cofilin Signaling Pathway via Extracellular Matrix-Integrin Interactions Is Critical for the Generation of Mature and Vascularized Cardiac Organoids. | Cells | 2023 | 37626839 | PubTator, text mining | PubMed |
| The role of m6A-modified CircEPHB4 in glioma pathogenesis: Insights into cancer stemness metastasis. | Ann Clin Transl Neurol | 2023 | 37614011 | PubTator, text mining | PubMed |
| GNAQ R183Q somatic mutation contributes to aberrant arteriovenous specification in Sturge-Weber syndrome through Notch signaling. | FASEB J | 2023 | 37606556 | PubTator, text mining | PubMed |
| Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. | J Biomed Sci | 2023 | 37605155 | PubTator, text mining | PubMed |
| Research progress of circRNA in malignant tumour metabolic reprogramming. | RNA Biol | 2023 | 37599427 | PubTator, text mining | PubMed |
| Challenges and new technologies in adoptive cell therapy. | J Hematol Oncol | 2023 | 37596653 | PubTator, text mining | PubMed |
| Vein of Galen aneurysmal malformation in newborns: a retrospective study to describe a paradigm of treatment and identify risk factors of adverse outcome in a referral center. | Front Pediatr | 2023 | 37587977 | PubTator, text mining | PubMed |
| EphrinB2: Expression of a novel potential target in renal cell carcinoma. | Indian J Urol | 2023 | 37575160 | PubTator, text mining | PubMed |
| What's inside? | Indian J Urol | 2023 | 37575156 | PubTator, text mining | PubMed |
| Molecular Motifs in Vascular Morphogenesis: Vascular Endothelial Growth Factor A (VEGFA) as the Leading Promoter of Angiogenesis. | Int J Mol Sci | 2023 | 37569543 | PubTator, text mining | PubMed |
| EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. | Cancers (Basel) | 2023 | 37568780 | PubTator, text mining | PubMed |
| Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities. | Cancers (Basel) | 2023 | 37568749 | PubTator, text mining | PubMed |
| Direct differentiation of human pluripotent stem cells into vascular network along with supporting mural cells. | APL Bioeng | 2023 | 37564277 | PubTator, text mining | PubMed |
| Obtaining Functional Proteomics Insights From Thermal Proteome Profiling Through Optimized Melt Shift Calculation and Statistical Analysis With InflectSSP. | Mol Cell Proteomics | 2023 | 37562535 | PubTator, text mining | PubMed |
| Heterogeneity in leukemia cells that escape drug-induced senescence-like state. | Cell Death Dis | 2023 | 37543610 | PubTator, text mining | PubMed |
| Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and Therapy. | Life (Basel) | 2023 | 37511951 | PubTator, text mining | PubMed |
| Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal/Stem Cell-Based Therapies. | Cells | 2023 | 37508569 | PubTator, text mining | PubMed |
| Diverse p120RasGAP interactions with doubly phosphorylated partners EphB4, p190RhoGAP, and Dok1. | J Biol Chem | 2023 | 37507023 | PubTator, text mining | PubMed |
| Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function. | Front Oncol | 2023 | 37483501 | PubTator, text mining | PubMed |
| Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis. | J Pharm Pharmacol | 2023 | 37463100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=12